Clinical Trials Directory

Trials / Sponsors / AKARI Therapeutics

AKARI Therapeutics

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnNomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARR
Bullous Pemphigoid
Phase 32022-05-06
TerminatedNomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy
Thrombotic Microangiopathies
Phase 32021-02-01
TerminatedTopical rVA576 for Treatment of Atopic Keratoconjunctivitis
Keratoconjunctivitis, Atopic, Keratoconjunctivitis, Vernal, Conjunctivitis, Allergic
Phase 1 / Phase 22019-03-04
CompletedrVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects
Bullous Pemphigoid (BP)
Phase 22018-09-25
CompletedTreating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase 32018-06-07
CompletedCoversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase 22018-05-14
TerminatedrVA576 (Coversin) Long Term Safety and Efficacy Surveillance Study
Paroxysmal Nocturnal Hemoglobinuria
Phase 32017-03-13
CompletedCoversin in Paroxysmal Nocturnal Haemoglobinuria (PNH)
Paroxysmal Nocturnal Haemoglobinuria (PNH)
Phase 22016-02-01